• Research Articles

    Brings forth the most in-depth body of knowledge relating to guanidinoacetic acid metabolism, pathophysiology and nutritional supplementation

    READ LATEST PAPER
  • Review Articles

    Summarizing recent progress in guanidinoacetic acid research, from its role in neuromuscular diseases to GAA shortfall in clinical medicine

    READ LATEST PAPER
GAA in human nutrition

GAA in human nutrition

Guanidinoacetic acid (GAA) is a nutrient that has been used in human nutrition since the early 1950s. Recommended for…

Read more
Epileptogenic effects of GAA

Epileptogenic effects of GAA

Guanidinoacetic acid (GAA) accumulates in the genetic deficiency of the GAMT enzyme and it is believed to cause the…

Read more
Reducing  myopathies via GAA

Reducing myopathies via GAA

Performance and processing advantages have been noted in meat animal production when excess arginine is available in the diet.…

Read more
GAA biodynamics in cancer

GAA biodynamics in cancer

The renewal and iteration of chemotherapy drugs have resulted in more frequent long-term remissions for patients with multiple myeloma…

Read more

About GAA Science

GAA-science.com is an educational portal established to collect, classify and present the scientific studies on guanidinoacetic acid (GAA) in one place. The papers are collected from peer-reviewed academic journals and publications, and relevant scientific events.

Our mission is to collect unbiased data and provide current best evidence in making decisions about the use of GAA in health and disease.

read more
GAA and Insulin Secretion

Physiological roles of GAA

GAA could affect many aspects of human metabolism, including cellular bioenergetics, neuromodulation, or oxidant-antioxidant status.

Latest events

CCDS Virtual Conference

6th EAAP International Symposium on Energy and Protein Metabolism and Nutrition

22nd European Symposium on Poultry Nutrition (ESPN 2019)

VIEW ALL
200 +
JOURNAL ARTICLES
30 +
HUMAN TRIALS
20 +
Papers in 2022

GAA Fundamentals

Guanidinoacetic acid (also known as glycocyamine or betacyamine) is a normal constituent of human blood, urine, and breast milk.

Being a natural amino acid derivative and a metabolite in the urea cycle, GAA also appears as an intermediate in metabolic pathways of several amino acids, including glycine, serine and arginine. GAA is direct precursor of creatine, a key substrate for cellular energy.

  • CAS Registry # 362-97-6
  • PubChem CID 763
  • Chemical formula C3H7N3O2
  • Molar mass 117.1 g/mol

The natural daily turnover of GAA is balanced between endogenous production and kidney excretion; only a minimal amount of GAA is available from food sources (e.g. 10 mg of GAA per kg of meat).

PubChem Summary

Age related reference values for urine creatine and GAA in children

Carla Valongo, Maria Luís Cardoso, Pedro Domingues, et al.

Creatine and GAA transport at blood-brain and and blood‐CSF barriers

Olivier Braissant

Tackling guanidinoacetic acid for advanced cellular bioenergetics

Sergej M Ostojic

Creatine and guanidinoacetate content of human milk and infant formulas

Erica E Edison, Margaret E Brosnan, Khalid Aziz, John T Brosnan

Dr. Sergej Ostojic

GAA-science.com was created and administered by a research group headed by Sergej M. Ostojic, MD, PhD, Professor of Nutrition at the University of Agder and the University of Novi Sad, who has been involved in GAA research for over a decade.

  1. May 2010

    First registered human trial with GAA

    ClinicalTrials.gov
  2. March 2008

    GAA as feed additive in poultry

    Evonik Industries
  3. October 1951

    First use of GAA in human nutrition

    CalTech
  4. October 1934

    GAA isolated from urine of dogs and humans

    University of Kansas

Golden Legacy Articles

Betaine and GAA for chronic residuals of poliomyelitis
JAMA. 1952;150(9):851-3
Betaine and glyocyamine in treatment of poliomyelitis
N Engl J Med. 1953;248(15):621-3.
Creatine and GAA metabolism in muscle disease
Brain. 1953;76(2):299-310.
Glycocyamine and betaine in motor-neurone disease
Lancet. 1956;271(6953):1136-8
VIEW ALL